ASTH vs ARDT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

ASTH

43.4
AI Score
VS
ASTH Wins

ARDT

25.9
AI Score

Investment Advisor Scores

ASTH

43score
Recommendation
HOLD

ARDT

26score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ASTH ARDT Winner
Forward P/E 23.0415 10.4058 ARDT
PEG Ratio 0 0 Tie
Revenue Growth 48.5% -1.4% ASTH
Earnings Growth 110.5% -77.1% ASTH
Tradestie Score 43.4/100 25.9/100 ASTH
Profit Margin 1.1% 1.2% ARDT
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL ASTH

Relative Price Performance (Last 90 Days)

ASTH 1M: -4.0% · 3M: +5.3% ARDT 1M: +5.5% · 3M: +19.3%

Current Technical Phase

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $39.35

ARDT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 54

RSI (14): 54.4 · Price: $10.99

Fundamentals Snapshot

Metric ASTH ARDT
Market Cap
Forward P/E 11.1 9.0
Trailing P/E 47.8 19.4
Revenue (TTM)
Revenue Growth 0.5% 0.0%
Gross Margin 0.1% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.81 0.54
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.